Led by two biotech titans, Yumanity Therapeutics announced its launch Monday.

If you got soaked this summer as part of the ice bucket challenge, you hopefully realize the need for treatments for diseases like Lou Gehrig’s disease, or ALS. Today, over 5o million people in the world suffer from such neurodegenerative diseases like Alzheimer’s, Parkinson’s, or ALS, and cost for treating those them now hovers at more than $650 billion a year.

But a new Cambridge-based company, Yumanity Theraputics, which just announced its launch this morning, has brought together a powerhouse biotech team in the hopes that they’ll tackle these diseases with force.More →

After a successful Kickstarter campaign, the miniPCR will now be available for classrooms Photo: via Ampylus

When Sebastian Kraves and Ezequiel “Zeke” Alvarez-Saavedra were growing up in Argentina, the science labs in their high school classrooms had only the most basic equipment. But the tools at their disposal were enough to spark an interest in biology that eventually led them both to Boston: Kraves received his doctorate in neurobiology from Harvard, while Alvarez-Saavedra took home a PhD in biology from MIT.More →

Grocery store shelf

Shelfie is not only an au courant name for an app, but a cool concept for these next few weeks of retail frenzy. Once you have the Android or iPhone apps, whenever there’s a product you’re hunting for that’s out-of-stock, you use it to snap a picture of the empty shelf. The info about what’s not there will be valuable to both retailers and product manufacturers, Shelfie posits. The shopper’s reward? Points that can be converted into gift cards for use at places like Starbucks, Amazon, or Target.More →